Identification of secondary prevention patients eligible for PCSK9 inhibitors therapy according to the routine clinical practice in Spain

The above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). 

© The authors, CC-BY-NC 2022.